$RGNT
Regentis Biomaterials Ltd.
NYSE · Healthcare · Orthopedic, Prosthetic & Surgical Appliances & Supplies · Or Akiva
RGNT chart
What traders are saying about $RGNT
Latest postsRegentis Biomaterials Ltd. news
- 12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga ·
- Regentis Biomaterials Ltd. Estimates – AMEX:RGNT
TradingView ·
- Regentis Biomaterials Pushes Durable Cartilage Repair as Orthopedics Shifts Toward Long-Term Outcomes
citybuzz - ·
- Regentis Biomaterials Reports Strong Surgeon Interest in GelrinC(R) at 8th ICRS Summit in Portugal
Yahoo Finance ·
- Regentis Biomaterials to Present at the 2026 ThinkEquity Conference on October 15 in New York City
Yahoo Finance ·
- IBN Announces Latest Episode of The BioMedWire Podcast Featuring Dr. Ehud Geller, CEO of Regentis Biomaterials Ltd.
Yahoo Finance ·
- Regentis Biomaterials (RGNT) Advances GelrinC as a Potential New Approach to Knee Cartilage Repair
Yahoo Finance ·
- Regentis Biomaterials Reports First Half 2026 Financial Results and Provides Corporate Update
Yahoo Finance ·
- Regenerative Hydrogel Is Redefining Cartilage Repair as Regentis Advances GelrinC
Yahoo Finance ·
- Regentis Biomaterials (RGNT) Moves GelrinC Along Parallel US Clinical and European Commercial Tracks
Yahoo Finance ·
- Regentis Biomaterials (RGNT) Builds a Manufacturing and Intellectual Property Powerhouse for the Global Cartilage Repair Market
Yahoo Finance ·
- Regentis Biomaterials (RGNT) Advances Regenerative Solution for Major Unmet Need in Cartilage Repair
Yahoo Finance ·
Regentis Biomaterials Ltd. key financials
| USD | 2025 | 2024 | 2023 |
|---|---|---|---|
| Net income | -$13.6M | $4.8M | -$4.1M |
| Diluted EPS | $-24.16 | $1.72 | $-24.09 |
| Total assets (year end) | $7.6M | $482,000 | – |
| Cash and equivalents (year end) | $7.4M | – | – |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
- 6-KREPORT OF FOREIGN PRIVATE ISSUER
- 6-KREPORT OF FOREIGN PRIVATE ISSUER
- 6-KREPORT OF FOREIGN PRIVATE ISSUER
- 6-KREPORT OF FOREIGN PRIVATE ISSUER
- 6-KREPORT OF FOREIGN PRIVATE ISSUER
- 6-KREPORT OF FOREIGN PRIVATE ISSUER
- 6-KREPORT OF FOREIGN PRIVATE ISSUER
- 6-KREPORT OF FOREIGN PRIVATE ISSUER
- 6-KREPORT OF FOREIGN PRIVATE ISSUER
- 6-KREPORT OF FOREIGN PRIVATE ISSUER
- 20-FANNUAL REPORT
- 6-KREPORT OF FOREIGN PRIVATE ISSUER
About Regentis Biomaterials Ltd.
- Ticker
- RGNT (NYSE)
- Industry
- Orthopedic, Prosthetic & Surgical Appliances & Supplies
- Headquarters
- Or Akiva
- Incorporated in
- Israel
- Fiscal year end
- December 31
- SEC CIK
- 1912966
Frequently asked questions
What exchange is Regentis Biomaterials Ltd. listed on?
Regentis Biomaterials Ltd. trades on the NYSE under the ticker symbol RGNT.
What industry is Regentis Biomaterials Ltd. in?
Regentis Biomaterials Ltd. is classified by the SEC under "Orthopedic, Prosthetic & Surgical Appliances & Supplies", part of the Healthcare sector on StockTweeting.
Where is Regentis Biomaterials Ltd. headquartered?
Regentis Biomaterials Ltd.'s business address on file with the SEC is in Or Akiva.
When does Regentis Biomaterials Ltd.'s fiscal year end?
Regentis Biomaterials Ltd.'s fiscal year ends on December 31.